Drug Profile
Rizatriptan intranasal - Benuvia Therapeutics
Alternative Names: Rizatriptan intranasal spray - INSYS Therapeutics; Rizatriptan nasal sprayLatest Information Update: 29 Feb 2024
Price :
$50
*
At a glance
- Originator INSYS Therapeutics, Inc
- Developer Benuvia Therapeutics; INSYS Therapeutics, Inc
- Class Antimigraines; Small molecules; Triazoles; Tryptamines
- Mechanism of Action Serotonin 1B receptor agonists; Serotonin 1D receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
- Available For Licensing Yes
Highest Development Phases
- Phase I Migraine